Where would you like to sign in?

Liberator Medical Reports Record Net Revenues and Earnings for the Third Fiscal Quarter Ended June 30, 2009

Net Revenues Exceed $6.9 Million for the Quarter Ended June 30, 2009, Up 184% Over Prior Year's Comparable Quarter

STUART, FL--(Marketwire - August 3, 2009) - Liberator Medical Holdings, Inc. (OTCBB: LBMH)
today announced net revenues of approximately $6.9 million for the third
fiscal quarter ended June 30, 2009, representing an annualized revenue run
rate of $27.6 million. Earnings for the quarter increased to approximately
$790,000, or $0.02 per share on a weighted average of 32,132,943 shares
outstanding.

Net Revenues for the third quarter 2009 increased 184% from $2.4 million
for the quarter ended June 30, 2008. Earnings increased to approximately
$790,000 from a net loss of ($217,835) for the quarter ended June 30, 2008.

The Company achieved quarter-over-quarter net revenue growth of 19% or $1.1
million for the quarter ended June 30, 2009 from $5.8 million of net
revenues for the second quarter ended March 31, 2009. Earnings rose
approximately $695,000 quarter-over-quarter from $94,947 for the second
quarter of 2009.

For the nine months ended June 30, 2009, the Company recorded net revenues
of $18.1 million, up 242% from $5.30 million for the nine-month period
ended June 30, 2008. Earnings for the nine months ended June 30, 2009,
were approximately $1.1 million or $0.04 per share on a weighted average of
32,067,847 shares outstanding, compared to a net loss of ($1,442,006) or
($0.05) per share on a weighted average of 31,683,081 shares outstanding
for the nine months ended June 30, 2008.

Mark Libratore, the Company's President and CEO, commented, "We are very
pleased with the Company's results for the quarter and the nine months
ended June 30, 2009. We attribute our success to our substantial
advertising campaign, exceptional customer service and recurring revenue
model."

Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply,
Inc., established the Liberator brand as a leading national
direct-to-consumer provider of quality medical supplies to
Medicare-eligible seniors. An Exemplary Provider™ accredited by The
Compliance Team, its unique combination of marketing, industry expertise
and customer service has demonstrated success over a broad spectrum of
chronic conditions. Liberator is recognized for offering a simple, reliable
way to purchase medical supplies needed on a regular, ongoing, repeat-order
basis, with the convenience of direct billing to Medicare and private
insurance. Approximately 85% of its revenue comes from supplying products
to meet the rapidly growing requirements of general medical supplies,
personal mobility aids, diabetes, urological, ostomy and mastectomy
patients. Liberator communicates with patients and their doctors on a
regular basis regarding prescriptions and supplies. Customers may purchase
by phone, mail or internet, with repeat orders confirmed with the customer
and shipped when needed.

Safe Harbor Statement

Certain statements in this press release that are not historical, but are
forward-looking, and are subject to known and unknown risks and
uncertainties which may cause the Company's actual results in future
periods to be materially different from any future performance that may be
suggested in this press release. Such risks and uncertainties may include,
but are not limited to, the Company's need to raise equity capital and its
ability to obtain equity financing on acceptable terms, if at all,
regulatory limitations on the medical industry in general, working capital
constraints, fluctuations in customer demand and commitments, fluctuation
in quarterly results, introduction of new services and products, commercial
acceptance and viability of new services and products, pricing and
competition, reliance upon subcontractors and vendors, the timing of new
technology and product introductions, the risk of early obsolescence of our
products and the other factors listed under "Risk and Uncertainties" in our
annual report on Form 10-KSB for the fiscal year ended September 30, 2008
and our other filings with the Securities and Exchange Commission. We
assume no obligation to update the information contained in this news
release.